Penumbra, Inc. to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

ALAMEDA, Calif., Nov. 5, 2015 — Penumbra, Inc. (NYSE: PEN), a global interventional therapies company, today announced that its management team is scheduled to present at the Canaccord Genuity Medical Technologies and Diagnostics Forum in New York, NY.

Event: Canaccord Genuity Medical Technologies & Diagnostics Forum
Date: Thursday, November 19, 2015
Time: 10:30 am ET / 7:30 am PT

An audio webcast of the presentation will be available by visiting the investors section of the Company's website at The webcast will be available on the Company's website for two weeks following the event.

About Penumbra
Penumbra, Inc., headquartered in Alameda, California is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. The company has a broad portfolio of products that address challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the U.S., most of Europe, Canada and Australia, and through distributors in select international markets. Penumbra and the Penumbra logo are trademarks of Penumbra, Inc.

Sara Thompson
Head of Investor Relations
Penumbra, Inc.
510 995 2455

SOURCE Penumbra, Inc.


Contact us to learn more about our products and company